Literature DB >> 2023415

Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer.

M Makino1, S Moriwaki, M Yonekawa, M Oota, O Kimura, N Kaibara.   

Abstract

To confirm the prognostic significance of the number of the metastatic lymph nodes (MLN) in cases of gastric cancer, the results of surgical treatment of 668 patients with primary gastric cancer were analyzed retrospectively. Five-year survival rates were calculated with reference to the number of MLN, namely, none (89.2%), one to three (77.4%), four to six (55.8%), and seven or more (36.2%). Furthermore, even when the cancer had invaded the serosa, 5-year survival was significantly more frequent in patients with one to three MLN (71.7%) than in those with four to six (35.5%) or more than six (31.5%) (P less than 0.01), and the 5-year survival was close to that of patients with no MLN (70.5%). Not only qualitative but also quantitative evaluation of lymph node metastasis is essential for estimating the prognosis of patients with gastric cancer.

Entities:  

Mesh:

Year:  1991        PMID: 2023415     DOI: 10.1002/jso.2930470104

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

2.  Impact of Combination Criteria of Nodal Counts and Sizes on Preoperative MDCT in Advanced Gastric Cancer.

Authors:  Tsutomu Kawaguchi; Daisuke Ichikawa; Shuhei Komatsu; Toshiyuki Kosuga; Takeshi Kubota; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Chouhei Sakakura; Eigo Otsuji
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

3.  CD54 expression is predictive for lymphatic spread in human gastric carcinoma.

Authors:  Masakazu Yashiro; Takeshi Sunami; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 4.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

5.  Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Authors:  M Lise; D Nitti; A Marchet; T Sahmoud; N Duez; A Fornasiero; J G dos Santos; R Labianca; P Lasser; M Gignoux
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

6.  Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; W Y Lui; F K P'eng
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.

Authors:  T Fujihara; T Sawada; K Hirakawa; Y S Chung; M Yashiro; T Inoue; M Sowa
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 8.  Significance of Lymph Node Metastasis in the Treatment of Gastric Cancer and Current Challenges in Determining the Extent of Metastasis.

Authors:  Shinichi Kinami; Hitoshi Saito; Hiroyuki Takamura
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.